Call us now

07315127344

Send Inquiry

Request To Call Back

5mg Apixab Tablets

Get a Price/Quote

MOQ : 10 Strips

5mg Apixab Tablets Specification

Brand Name
Apixab

Life Span
24 months from manufacture date

Indication
Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treatment and prevention of DVT and PE

Packaging Type
Blister pack

Pacakaging (Quantity Per Box)
30 tablets

Dosage Form
Oral tablet

Salt Composition
Apixaban

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Apixaban 5 mg

Physical Form
Tablets

Function
Anticoagulant - prevents blood clot formation

Recommended For
Patients at risk of stroke or systemic embolism due to nonvalvular atrial fibrillation, and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

Dosage
As directed by physician, typically 5 mg twice daily

Dosage Guidelines
Take orally as prescribed; do not crush or chew tablets

Suitable For
Adults

Quantity
30 tablets per box

Storage Instructions
Store in a cool, dry place, below 30C. Protect from light and moisture.

Marketed By
As per brand approval

Maximum Shelf Life
2 years

Barcode
Present

Patient Advice
Follow doctor's instruction; do not stop suddenly

Therapeutic Class
Direct Factor Xa Inhibitor

Language on Packaging
English

Batch Number
As mentioned on package

MRP
As per pack

Contraindications
Active pathological bleeding, severe hepatic impairment

Colour
Light pink

Tablet Markings
Embossed with dosage/brand name as per manufacturer

Route of Administration
Oral

Shape
Round

Side Effects
Bleeding, bruising, nausea

Approval
USFDA/EMEA approved active ingredient

Prescription Required
Yes

5mg Apixab Tablets Trade Information

Minimum Order Quantity
10 Strips

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Strips Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 5mg Apixab Tablets

Discover affordable excellence with Apixab 5mg Tablets, a top-rated anticoagulant containing praiseworthy Apixaban, approved by USFDA/EMEA authorities. Crafted in a polished, round, light pink oral tablet, Apixab delivers a glorious balance of safety and efficacy at the lowest price. Designed for adults, it helps prevent stroke, systemic embolism, DVT, and PE with prescription use. Each blister pack contains 30 meticulously embossed tablets. With a 24-month shelf life and batch details on the package, trust Apixab for premium care. Follow your physician's guidance and store correctly for optimal results.

Apixab 5mg Tablets: Usage & Applications

Apixab 5mg Tablets are primarily used for the prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation, as well as for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). These tablets boast a polished round surface, are light pink in color, and are administered orally. Their reliable anticoagulant action prevents blood clot formation, making them essential for individuals at risk of these conditions. Dosage is strictly as directed by a physician.

Apixab 5mg Tablets: Packaging, Sample, and Market Details

Apixab 5mg Tablets are securely packaged in premium blister packs, with 30 tablets in each box, ensuring product safety and integrity. Every shipment is handled with quick dispatch protocols to provide timely delivery. The product carries batch numbers and barcodes for authenticity. A sample may be available based on supplier policy. Apixab is primarily supplied across the main domestic market in India, meeting stringent quality standards for effective therapeutic use.

FAQ's of 5mg Apixab Tablets:

Q: How should Apixab 5mg Tablets be taken for best results?

A: Apixab 5mg Tablets should be taken orally, as prescribed by your physician-typically 5 mg twice daily. Do not crush or chew the tablets and always follow your doctor's guidance.

Q: What are the main benefits of using Apixab 5mg Tablets?

A: These tablets are effective in preventing stroke and systemic embolism in patients with nonvalvular atrial fibrillation and treating or preventing deep vein thrombosis (DVT) and pulmonary embolism (PE).

Q: When is Apixab 5mg contraindicated?

A: Apixab 5mg should not be taken by individuals with active pathological bleeding or severe hepatic impairment, as these conditions can increase safety risks.

Q: What precautions should patients follow while on Apixab 5mg?

A: Patients should strictly follow medical advice, avoid stopping the medication suddenly, and report any unusual bleeding or bruising to their doctor.